Corpus Intelligence IC Memo — SCOTTISH RITE CHILDRENS MEDICAL CTR 2026-04-26 04:05 UTC
IC Memo — SCOTTISH RITE CHILDRENS MEDICAL CTR
Investment Committee Memorandum | GA | 319 beds | Grade B | EBITDA uplift $66.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SCOTTISH RITE CHILDRENS MEDICAL CTR

CCN 113301 | FULTON, GA | 319 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

SCOTTISH RITE CHILDRENS MEDICAL CTR is a 319-bed suburban community hospital in FULTON, GA with $905.6M in net patient revenue and a 44.8% operating margin. The hospital serves a payer mix of 0.0% Medicare, 18.2% Medicaid, and 81.8% commercial.

Thesis: Platform Growth. Our ML models identify $66.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 44.8% to 52.2% (+736bps).

Net Revenue HCRIS$905.6M
Current EBITDA COMPUTED$405.9M
Operating Margin COMPUTED44.8%
Occupancy HCRIS73.3%
Revenue / Bed COMPUTED$2.8M
Net-to-Gross HCRIS44.4%
Distress Probability ML45.0%

2. Market Context & Competitive Position

165
GA Hospitals
-2.8%
State Median Margin
43
Comparable Hospitals

GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of 44.8% places it above the state median. Among 43 size-comparable peers (160-638 beds), the median margin is -2.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (160-638), prioritizing same-state peers. 43 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SCOTTISH RITE CHILDRENS MEDICA (Target)GA319$905.6M44.8%
EMORY UNIVERSITY HOSPITAL MIDTGA548$1.37B-15.4%
PIEDMONT HOSPITAL INC.GA569$1.32B4.0%
NORTHSIDE HOSPITAL - GWINNETTGA404$1.07B-2.5%
EGLESTON CHILDRENS HOSPITAL ATGA330$941.9M41.5%
COBB HOSPITAL AND MEDICAL CENTGA367$897.0M6.1%
AU MEDICAL CENTER INCGA494$789.4M-35.7%
AHN THE MEDICAL CENTERGA632$767.3M-0.1%
MEMORIAL HEALTH UNIV MED CENTEGA564$708.4M-1.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $66.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$19.0M+210bp18mo
Cost to Collect4.5%2.5%$18.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$17.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$11.0M+122bp9mo
Clean Claim Rate88.0%96.0%$580K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$19.0M
Cost to Collect
$18.1M
Denial Rate Reduction
$17.9M
A/R Days Reduction
$11.0M
Clean Claim Rate
$580K
Total EBITDA Uplift$66.7M
Current EBITDA$405.9M
+ RCM Uplift+$66.7M
Pro Forma EBITDA$472.5M
Current Margin44.8%
Pro Forma Margin52.2%
WC Released (1x)$34.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$624.4M$3.34B5.36x39.9%
Base (11x exit)10.0x11.0x$624.4M$3.88B6.22x44.1%
Bull Case9.0x11.0x$562.0M$4.30B7.66x50.2%
Bull (12x exit)9.0x12.0x$562.0M$4.86B8.65x54.0%
Bear Case11.0x10.0x$686.9M$2.81B4.09x32.5%
Bear (11x exit)11.0x11.0x$686.9M$3.31B4.82x37.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 43 hospitals with 160-638 beds
  • Same-state prioritization (n=44)
  • Comp margins: P25=-14.7% / P50=-2.5% / P75=4.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.